- Display 15 Products per page
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments – World Market
Published: May 1, 2007 | Price: $995.00 – $3,990.00
Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market from Kalorama Information. One of the most promising new approaches in modern cancer treatment is immunotherapy, the development of methods to augment and enhance the...
MRI: World Market Analysis, Forecasts to 2018
Published: November 24, 2014 | Price: $995.00 – $1,990.00
MRI: World Market Analysis Medical imaging has led to improvements in the diagnosis and treatment of numerous medical conditions in children and adults. There are many types of medical imaging procedures, each of which uses different technologies and techniques. MRI is a noninvasive medical diagnostic technique that uses a magnetic field and radio waves to create detailed images of the organs and tissues within the body. MRI machines are used to produce cross-sectional MRI images and three-dimensional images that may...
Multiple Sclerosis Treatments: World Market Outlook to 2011
Published: June 1, 2007 | Price: $500.00 – $5,990.00
Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although there is no cure, approved treatments are available to slow the progression of MS and offer improved quality of life. Kalorama Information's: Multiple Sclerosis Treatments: World Market Outlook to 2011 is one of the few publications to take a detailed look at multiple sclerosis treatment market worldwide, as well as treatments that...
NASH Drug Pipeline and Market Overview
Published: January 6, 2020 | Price: $2,000.00 – $4,000.00
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate....
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics
Published: July 1, 2011 | Price: $150.00 – $300.00
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry and the needle-free drug delivery market will continue to grow rapidly. This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives...
Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
Published: February 18, 2006 | Price: $2,200.00 – $5,990.00
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can...
Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”
Published: January 1, 2003 | Price: $1,121.00 – $1,717.00
In the summer of 2002, Kalorama Information released a major study on non-psychiatric neurotherapeutic drug markets. At almost 500 pages, the resulting report covered a broad range of neurological agents comprehensively and in depth; however, the breadth and authority of the results proved to be more information than some marketers needed. Smaller biopharmaceutical concerns—some of the real drivers of this market—are more focused on individual neurological disorders such as multiple sclerosis, Alzheimer’s disease, or neurological cancers, rather than the broad...
Neurological Catheters: A Market Briefing
Published: February 1, 2005 | Price: $995.00 – $1,990.00
Neurological catheters, also known as microcatheters, are small devices that can navigate the intricate intracranial vasculature of the brain. These catheters--some on the market, others in development--are used for a variety of applications, including aneurysm occlusion, chronic pain relief, targeted drug delivery, tumor embolization, treating vascular malformations, brachytherapy, and vasospasm therapy. They also promise to be extremely useful in the delivery of therapeutic genes or stem cells to patients who may have a variety of neurological diseases. This report analyzes...
New Anticoagulant Therapies: A Market Briefing
Published: October 1, 2004 | Price: $895.00 – $1,790.00
There is a pressing need for new anticoagulant therapeutics in human medicine. To meet this need, developers are reformulating traditional cornerstone therapeutics such as heparin and looking to new classes such as DTIs to prevent stroke and myocardial infarction and treat deep vein thrombosis and a host of other emerging indications. This briefing analyzes the potential world medical markets for new anticoagulant therapies. Revenue projections through 2010 are made for four geographic regions and for two potentially blockbuster products. This...
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)
Published: January 23, 2015 | Price: $995.00 – $7,000.00
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends) This report, Next-Generation Sequencing Markets (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Trends, Platforms, Applications, Brand Ownership) provides sizing and forecasts within this growing market. The first sequencing-based clinical diagnostic tests have been cleared by the FDA, and more will follow. Some next generation sequencing competitors developing kits that can be produced and sold to clinical laboratories following the standard...
Next Generation Sequencing Market by Product Type (Instrumentation, Consumables, Services), Application (Research, Clinical), by Method (Sanger, Next-Generation) and by Geographic Region.
Published: April 16, 2018 | Price: $4,500.00 – $9,000.00
Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends) Next generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next Generation Sequencing Markets...
Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)
Published: September 7, 2016 | Price: $2,000.00 – $4,000.00
This report, Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms) covers the market for NGS including a market estimate and a projection to 2020, regional growth for North America, Europe and Other regions, markets by disease category and instrument popularity from lab self reporting surveys. The report also covers investments in sequencing, trends and detail about manufacturers and service companies in NGS. A unique feature of this report is its focus on the interplay between...
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends)
Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...
Next-Generation Sequencing in Latin America
Published: January 23, 2014 | Price: $995.00 – $1,990.00
Next-Generation Sequencing in Latin America This report is an examination of the use of DNA sequencing systems in the Latin American region, based on a survey conducted in Fall 2013 by VA Consultadoros. The survey centered on instrumentation, with a goal of providing a complete count of next-generation sequencing (NGS) systems sold to customers in the major countries of Latin American. For the healthcare industry, Latin America is a focus. The region went through its highest economic growth period in...
Next-Generation Sequencing Trends: Kalorama Survey of Laboratories
Published: November 21, 2017 | Price: $3,600.00 – $7,200.00
Next-Generation Sequencing Trends: Kalorama Survey of Laboratories Next-Generation Sequencing Trends: Kalorama Survey of Laboratories identifies some of the key changes taking place with both next-generation sequencing (NGS) systems in relation to their usage in labs and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes. The report surveys the following aspects of NGS systems: system installations; sequencer applications, clinical applications, and usage trends; preferences and evaluations; and future purchase plans. This survey – of 78...